Murad Alam, MD, MSCI, MBA; Rosemara Hughart, MD; Amelia Geisler, BS; et al.
free access
JAMA Dermatol. 2018;154(7):765-772. doi:10.1001/jamadermatol.2018.0515
This parallel-group, randomized clinical trial assesses the effectiveness and dose-related effect of small quantities of hyaluronidase vs saline to treat hyaluronic acid filler nodules in healthy women.
Mary Kay Koenig, MD; Cynthia S. Bell, MS; Adelaide A. Hebert, MD; et al.
free access
has audio
JAMA Dermatol. 2018;154(7):773-780. doi:10.1001/jamadermatol.2018.0464
This randomized clinical trial examines the efficacy and safety of topical rapamycin therapy for treatment of patients with tuberous sclerosis complex–related facial angiofibromas.
-
Audio Author Interview:
Topical Rapamycin in Patients With Facial Angiofibromas
Mari Wataya-Kaneda, MD, PhD; Yuuki Ohno, MD; Yasuyuki Fujita, MD, PhD; et al.
open access
JAMA Dermatol. 2018;154(7):781-788. doi:10.1001/jamadermatol.2018.1408
This randomized clinical trial assesses the efficacy and safety of sirolimus gel, 0.2% vs placebo for treatment of angiofibromas and skin lesions in adult and pediatric patients with tuberous sclerosis complex.
Judith Wendt, MD, PhD; Christoph Mueller, MD; Sabine Rauscher, MSc; et al.
free access
JAMA Dermatol. 2018;154(7):789-795. doi:10.1001/jamadermatol.2018.1252
This case-control study evaluates the association of melanocortin-1-receptor (MC1R) with melanoma risk in males vs females, adjusting for risk factors such as age, pigmentation, phenotype, signs of skin damage, and sun exposure.
Mathieu Jouvray, MD; David Launay, MD, PhD; Sylvain Dubucquoi, MD, PhD; et al.
free access
JAMA Dermatol. 2018;154(7):796-805. doi:10.1001/jamadermatol.2018.0916
This cross-sectional study evaluates the association between the presence and distribution of telangiectases and the severity of vasculopathy in patients with systemic sclerosis.
Theodore Rosen, MD; Nuria Albareda, BS; Noah Rosenberg, MD; et al.
free access
JAMA Dermatol. 2018;154(7):806-813. doi:10.1001/jamadermatol.2018.1103
This randomized clinical trial evaluates the efficacy, safety, and tolerability of ozenoxacin cream vs placebo in children and adults with impetigo.
Amit Garg, MD; Jessica Hundal, BA; Andrew Strunk, MA
free access
JAMA Dermatol. 2018;154(7):814-818. doi:10.1001/jamadermatol.2018.0878
This cross-sectional cohort analysis of electronic health records from a large US database evaluates overall and subgroup prevalence of Crohn disease among patients with hidradenitis suppurativa.